Sharps Technology, Inc.

Sharps Technology, Inc.

STSS·NASDAQ

$1.84

+1.1%
HealthcareMedical - Instruments & Supplies

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

At a Glance

Live Snapshot
Market Cap$77.87M
EPS-11.1600
P/E Ratio-0.18
Earnings Date09/02/2026

stss

EPS

Last Annual Value

-11.16

3-Year CAGR

86%

5-Year CAGR

42%

10-Year CAGR

20%

Sharps Technology, Inc.

Sharps Technology, Inc. Competitors Analysis of EPS

STSS · NASDAQ
CompanyEPS
CAGR 3Y
CAGR 5Y
CAGR 10Y
-11.16
N/AN/AN/A 
JYNT logo
The Joint Corp.
NASDAQ:JYNT
0.19
N/A-16.2%N/A
-0.29
N/AN/AN/A
-1.43
N/AN/AN/A
HYPR logo
Hyperfine, Inc.
NASDAQ:HYPR
-0.43
N/AN/AN/A
-14.78
N/AN/AN/A
-0.69
N/AN/AN/A
-0.06
N/AN/AN/A
-1.32
N/AN/AN/A
OWLT logo
Owlet, Inc.
NYSE:OWLT
-2.24
N/AN/AN/A
3.41
-9.3%-3.4%0.6%
Sharps Technology, Inc.

Sharps Technology, Inc. Fair Value Envelope

STSS · NASDAQ

Our analysis suggests that STSS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.84, this represents a potential HIDDEN relative to our calculated worth for Sharps Technology, Inc..

Intrinsic Value
Current Price: $1.84